股价严重异动！博瑞医药连续30个交易日内收盘价跌幅偏离值累计达到70%

Core Viewpoint - 博瑞医药's stock has experienced a significant decline, with a cumulative drop of 70% over the last 30 trading days, indicating severe abnormal trading fluctuations [1] Company Summary - As of September 24, 博瑞医药's closing price was 72.5 yuan per share [1] - The latest rolling price-to-earnings (P/E) ratio for 博瑞医药 is 313.01, which is substantially higher than the average rolling P/E ratio of 31.43 for the pharmaceutical manufacturing industry over the past month [1] - 博瑞医药 has conducted a self-inspection and reported that its daily operations are normal, with no significant changes or fluctuations in production costs and sales [1] Industry Summary - The pharmaceutical manufacturing industry has an average rolling P/E ratio of 31.43, highlighting 博瑞医药's significantly elevated valuation compared to its peers [1]